
| Serial Number | 88819213 |
| Word Mark | S SEBELA PHARMACEUTICALS |
| Filing Date | Tuesday, March 3, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 7, 2022 |
| Registration Number | 6749663 |
| Registration Date | Tuesday, June 7, 2022 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 22, 2022 |
| Description of Mark | The mark consists of the stylized wording "SEBELA" in turquoise above the word "PHARMACEUTICALS" in grey, appearing to the right of a stylized reverse letter "S" with a horizontal line and three dots all in grey. |
| Goods and Services | Pharmaceutical preparations for use in treating dermatology, gastroenterology, rheumatology, and psychiatric disorders; Pharmaceutical preparations for use in the treatment of pain and inflammation; Pharmaceutical preparations directed to women's health for use in the treatment, alleviation and prevention of thermoregulatory dysfunctions and vasomotor symptoms including hot flashes, hot flushes, night awakenings, night sweats, and such disorders and conditions associated with perimenopause, menopause and hormonal deficiencies; Menstrual symptom treatment preparations; Pharmaceutical preparations for use in treating nephrology, neurology, oncology, urology, andrology and cardiology diseases and disorders, and for use in the treatment of nasal allergies, respiratory allergies, and for use as anti-infectives; contraceptive preparations; dietary and nutritional supplements; prenatal vitamins; pharmaceutical preparations for the treatment of bone diseases; preparations for the suppression of hormones; pharmaceutical preparations directed to women's health for use in the treatment, alleviation and prevention of overactive bladder, female sexual dysfunction, infertility, endometriosis, vaginitis, osteoporosis, osteopenia, pelvic pain, dyspareunia, and candidiasis; Diagnostic agents, preparations and substances for medical purposes; all of the aforesaid goods not for use as a product name of a pharmaceutical product |
| Indication of Colors claimed | The color(s) grey and turquoise is/are claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 9, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Sebela Ireland Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 11 - Company |
| Address | Dublin 8 IE |
| Party Name | Sebela Ireland Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 11 - Company |
| Address | Dublin 8 IE |
| Party Name | Sebela Ireland Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 11 - Company |
| Address | Dublin 8 IE |
| Event Date | Event Description |
| Tuesday, June 7, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, June 7, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 22, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 22, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 2, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, February 17, 2022 | ELECTRONIC RECORD REVIEW COMPLETE |
| Friday, September 10, 2021 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, September 8, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, September 7, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 7, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, September 7, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 5, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, March 5, 2021 | NON-FINAL ACTION E-MAILED |
| Friday, March 5, 2021 | NON-FINAL ACTION WRITTEN |
| Thursday, March 4, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, March 4, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 2, 2021 | ASSIGNED TO LIE |
| Wednesday, December 2, 2020 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Saturday, November 21, 2020 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Saturday, November 21, 2020 | INQUIRY TO SUSPENSION E-MAILED |
| Saturday, November 21, 2020 | SUSPENSION INQUIRY WRITTEN |
| Thursday, May 21, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, May 21, 2020 | LETTER OF SUSPENSION E-MAILED |
| Thursday, May 21, 2020 | SUSPENSION LETTER WRITTEN |
| Thursday, May 21, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, March 10, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, March 9, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, March 6, 2020 | NEW APPLICATION ENTERED IN TRAM |